Synapse - Dean Bajorin

Search Within

Dean Bajorin

Results (663)

Associations of diet with survival of patients (pts) with metastatic cancer of the urothelium (mUC) and renal cell carcinoma (mRCC) on immune checkpoint blockade (ICB)

Meeting Abstract

Guercio, B. J.; Ratna, N.; Gavrilov, D.; Duzgol, C.; Akhlaq, M.; Teo, M. Y.; Regazzi, A. M.; Kotecha, R. R.; Funt, S. A.; Aggen, D. H.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Genome-wide association study of bladder cancer reveals new biological and translational insights

Journal Article

Koutros, S.; Kiemeney, L. A.; Pal Choudhury, P.; Milne, R. L.; Lopez de Maturana, E.; Ye, Y.; Joseph, V.; Florez-Vargas, O.; Dyrskjøt, L.; Figueroa, J.; more...
European Urology (2023)

Fulltext@MSK | Save

Treatment of muscle-invasive urothelial cancer with nivolumab (CheckMate 274 study): A plain language summary

Review

Bajorin, D. F.; Witjes, J. A.; Gschwend, J. E.; Schenker, M.; Valderrama, B. P.; Tomita, Y.; Bamias, A.; Lebret, T.; Shariat, S. F.; Park, S. H.; more...
Future Oncology (2023)

Fulltext@MSK | Save

Disease-free survival analysis for patients with high-risk muscle-invasive urothelial carcinoma from the randomized CheckMate 274 trial by PD-L1 combined positive score and tumor cell score

Journal Article

Galsky, M. D.; Bajorin, D. F.; Witjes, J. A.; Gschwend, J. E.; Tomita, Y.; Nasroulah, F.; Li, J.; Collette, S.; Valderrama, B. P.; Grimm, M. O.; more...
European Urology (2023)

Fulltext@MSK | Save

Final results of a phase I trial of WST-11 (TOOKAD Soluble) vascular-targeted photodynamic therapy for upper tract urothelial carcinoma

Journal Article

Yip, W.; Sjoberg, D. D.; Nogueira, L. M.; Tracey, A. T.; Alvim, R. G.; Reisz, P. A.; Demac, Q.; Benfante, N. E.; Vanden Berg, R. W.; Kim, K.; more...
Journal of Urology (2023)

Fulltext@MSK | Save

Multicenter phase II clinical trial of gemcitabine and cisplatin as neoadjuvant chemotherapy for patients with high-grade upper tract urothelial carcinoma

Journal Article

Coleman, J. A.; Yip, W.; Wong, N. C.; Sjoberg, D. D.; Bochner, B. H.; Dalbagni, G.; Donat, S. M.; Herr, H. W.; Cha, E. K.; Donahue, T. F.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

A phase II trial of intravesical chemoimmunotherapy with gemcitabine and bacillus Calmette-Guérin (BCG) for patients with BCG-exposed, high-grade, non-muscle–invasive bladder cancer

Meeting Abstract

Gaffney, C.; Dsouza, N.; Hernandez, C.; McCarter, M.; Moran, P.; Stasi, K.; Worth, K.; Dalbagni, G.; Donahue, T. F.; Donat, S. M.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Pembrolizumab (pembro) monotherapy for patients (pts) with high-risk non–muscle-invasive bladder cancer (HR NMIBC) unresponsive to bacillus Calmette–Guérin (BCG): Results from cohort B of the phase 2 KEYNOTE-057 trial

Meeting Abstract

Necchi, A.; Roumiguié, M.; Esen, A. A.; Lebret, T.; De Wit, R.; Shore, N. D.; Bajorin, D. F.; Krieger, L. E. M.; Kandori, S.; Uchio, E. M.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Extended follow-up results from the CheckMate 274 trial

Meeting Abstract

Galsky, M. D.; Witjes, A. A.; Gschwend, J. E.; Schenker, M.; Valderrama, B. P.; Tomita, Y.; Bamias, A.; Lebret, T.; Shariat, S. F.; Park, S. H.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Response Evaluation Criteria in Tumors of the Bladder (RECIT-Bladder) for future window of opportunity trials as a platform to accelerate drug development

Meeting Abstract

Gaffney, C.; Jiang, S.; de Jesus, M. R.; Chu, C. E.; Benfante, N.; Bajorin, D. F.; Donahue, T. F.; Rosenberg, J. E.; Iyer, G.; Bochner, B. H.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save